Thromb Haemost 1974; 32(02/03): 325-340
DOI: 10.1055/s-0038-1647702
Original Article
Schattauer GmbH

Reversible and Irreversible Alterations of Human Plasminogen Indicated by Changes in Susceptibility to Plasminogen Activators and in Response to ∈-Aminocaproic Acid

Sixtus Thorsen*
1   James F. Mitchell Foundation, Institute for Medical Research, Washington, D. C., U.S.A
,
Preben Kok
1   James F. Mitchell Foundation, Institute for Medical Research, Washington, D. C., U.S.A
,
Tage Astrup
1   James F. Mitchell Foundation, Institute for Medical Research, Washington, D. C., U.S.A
› Author Affiliations
Further Information

Publication History

Received 08 January 1974

Accepted 06 June 1974

Publication Date:
30 June 2018 (online)

Summary

Increasing concentrations of EACA produce a biphasic pattern of inhibition and enhancement of urokinase-induced lysis of bovine fibrin containing bovine plasminogen, while the inhibition of fibrinolysis induced by a porcine tissue plasminogen activator increases uniformly. The biphasic EACA pattern is also observed with human plasminogen in fibrinolytic and caseinolytic assays of urokinase. The biphasic EACA pattern produced with urokinase is related to the presence of a genuine form of plasminogen. The enhancement phase is caused by an increased rate of plasminogen activation in the presence of EACA. A brief treatment of genuine plasminogen with acid at ionic strength 0.15 results in an enhanced susceptibility to plasminogen activators and in a partial abolishment of the biphasic response. These acid-induced alterations of plasminogen seem to be reversed by acid dialysis at low ionic strength. Other preparations of plasminogen with enhanced susceptibility to activators have lost the ability to produce a biphasic pattern of inhibition and enhancement of urokinase-induced plasminogen activation in the presence of EACA and this ability does not return after acid dialysis at low ionic strength. EACA inhibits all plasmin preparations, whether prepared from genuine or altered forms of plasminogen, in the same uniform manner.

Our results show that different forms of plasminogen can be identified by differences in the susceptibilities to activators, by their response to EACA, and by the reversibility or irreversibility of the alterations.

* Present address: Department of Clinical Chemistry, Blegdamshospitalet, Copenhagen, Denmark.


 
  • References

  • 1 Abiko Y, Iwamoto M, Shimizu M. 1968; Plasminogen-plasmin system. I. Purification and properties of human plasminogen. Journal of Biochemistry (Tokyo) 64: 743.
  • 2 Abiko Y, Iwamoto M, Tomikawa M. 1969; Plasminogen-plasmin system. V. A stoichiometric equilibrium complex of plasminogen and a synthetic inhibitor. Biochimica et Biophysica Acta 185: 424.
  • 3 Alkjaersig N. 1964; The purification and properties of human plasminogen. Biochemical Journal 93: 171.
  • 4 Brakman P. 1965; Bovine fibrinogen without detectable plasminogen. Analytical Biochemistry 11: 149.
  • 5 Brakman P. 1967 Fibrinolysis. A Standardized Fibrin Plate Method and a Fibrinolytic Assay of Plasminogen. Scheltema and Holkema IST. V., Amsterdam..
  • 6 Brockway W. J, Castellino F. J. 1971; The mechanism of the inhibition of plasmin activity by s-aminocaproic acid. Journal of Biological Chemistry 246: 4641.
  • 7 Brockway W. J, Castellino F. J. 1972; Measurement of the binding of antifibrinolytic amino acids to various plasminogens. Archives of Biochemistry and Biophysics 151: 194.
  • 8 Claeys H, Molla A, Verstraete M. 1973. Digestion of human plasminogen by human plasmin. Proceedings of the Fourth International Congress on Thrombosis and Haemostasis. Vienna: 19-22 June 1973, Abstract #153.
  • 9 Deutsch D. G, Mertz E. T. 1970; Plasminogen: purification from human plasma by affinity chromatography. Science 170: 1095.
  • 10 Hink J. H, McDonald J. K. 1963; Preparation and immunochemistry of a human euglobulin profibrinolysin. Vox Sanguinis 08: 103.
  • 11 Hoepfinger L. M, Mertz E. T. 1969; Studies on plasminogen. VII. Mechanism of activation of bovine plasminogen. Canadian Journal of Biochemistry 47: 909.
  • 12 Hsu L-H. 1972 Personal communication.
  • 13 Kline D. L, Fishman J. B. 1961; Improved procedure for the isolation of human plasminogen. Journal of Biological Chemistry 236: 3232.
  • 14 Kok P, Astrup T. 1969; Isolation and purification of a tissue plasminogen activator and its comparison with urokinase. Biochemistry 08: 79.
  • 15 Kok P, Astrup T. 1972; Differentiation between plasminogen activators by means of epsilon-aminocaproic acid. Thrombosis et Diathesis Haemorrhagica 27: 77.
  • 16 Liu T. H, Mertz E. T. 1971; Studies on plasminogen. IX. Purification of human plasminogen from Cohn fraction III by affinity chromatography. Canadian Journal of Biochemistry 49: 1055.
  • 17 Lorand L, Condit E. V. 1965; Ester hydrolysis by urokinase. Biochemistry 04: 265.
  • 18 Müllertz S. 1955; Formation and properties of the activator of plasminogen and of human and bovine plasmin. Biochemical Journal 61: 424.
  • 19 Robbins K. C, Bernabe P, Arzadon L, Summaria L. 1973; NH2-terminal sequences of mammalian plasminogens and plasmin s-carboxymethyl heavy (A) and ligth (B) chain derivatives. A re-evaluation of the mechanism of activation of plasminogen. Journal of Biological Chemistry 248: 7242.
  • 20 Sgouris J. T, Inman J. K, McCall K. B, Hyndman L. A, Anderson H. D. 1960; The preparation of human fibrinolysis (plasmin). Vox Sanguinis 05: 357.
  • 21 Slotta K. H, Miohl H, Santos B. G. 1962; Comparative studies of native and acid-treated plasminogens. Biochemica et Biophysica Acta 58: 459.
  • 22 Thorsen S, Astrup T. 1969; Biphasic inhibition of urokinase-induced fibrinolysis by s-aminocaproic acid; distinction from tissue plasminogen activator. Proceedings of the Society for Experimental Biology and Medicine 130: 811.
  • 23 Thorsen S, Kok P, Astrup T. 1972. Molecular alterations of plasminogen disclosed dy the effects of s-aminocaproic acid (EACA) on fibrinolysis and caseinolysis induced by urokinase (UK). Federation Proceedings. 31, March-April, Abstract # 106.
  • 24 Thorsen S, Müllertz S, Kok P, Astrup T. 1974 Enhanced reactivity of reversibly and irreversibly altered forms of human plasminogen and the effect of eaminocaproic acid (EACA). Federation Proceedings. 33. Abstract #37.
  • 25 Wallen P, Wiman B. 1972; Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen. Biochemica et Biophysica Acta 257: 122.
  • 26 Wallen P, Wiman B. 1973 On the formation and properties of an intermediate form of human plasminogen generated during activation with urokinase. Proceedings of the Fourth International Congress on Thrombosis and Haemostasis. Vienna: 19-22 June 1973, Abstract #150.
  • 27 Walton P. L. 1967; The hydrolysis of α-N-Acetylglycyl-L-Lysine methyl ester by urokinase. Biochemica et Biophysica Acta 132: 104.